[HTML][HTML] Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova… - Frontiers in …, 2024 - frontiersin.org
Glioma is the most common primary brain tumor, characterized by a consistently high patient
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
T Mishchenko, V Turubanova, E Gorshkova… - Frontiers in …, 2023 - europepmc.org
Glioma is the most common primary brain tumor, characterized by a consistently high patient
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
[引用][C] Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova… - … in Immunology (Web), 2023 - jglobal.jst.go.jp
Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report:
primary brain and other central nervous system tumors diagnosed in the United States in …
primary brain and other central nervous system tumors diagnosed in the United States in …
[PDF][PDF] Glioma: bridging the tumor microenvironment, patient immune proles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova, EN Gorshkova… - 2024 - researchgate.net
Glioma, the most common and deadliest malignant primary brain tumor in adults, poses a
formidable challenge. However, despite the constant updating and improvement of …
formidable challenge. However, despite the constant updating and improvement of …
[HTML][HTML] Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Glioma is the most common primary brain tumor, characterized by a consistently high patient
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova… - Frontiers in …, 2024 - pubmed.ncbi.nlm.nih.gov
Glioma is the most common primary brain tumor, characterized by a consistently high patient
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova… - FRONTIERS IN …, 2024 - biblio.ugent.be
Glioma is the most common primary brain tumor, characterized by a consistently high patient
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
[PDF][PDF] Glioma: bridging the tumor microenvironment, patient immune proles and novel personalized immunotherapy
TA Mishchenko, VD Turubanova, EN Gorshkova… - 2024 - backoffice.biblio.ugent.be
Glioma, the most common and deadliest malignant primary brain tumor in adults, poses a
formidable challenge. However, despite the constant updating and improvement of …
formidable challenge. However, despite the constant updating and improvement of …
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.
TA Mishchenko, VD Turubanova… - Frontiers in …, 2024 - europepmc.org
Glioma is the most common primary brain tumor, characterized by a consistently high patient
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …
mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial …